EIF5A2 and ovarian carcinoma: eIF-5A was found to be overexpressed in samples from colorectal adenoma and eIF-5A2 is present in various cancer cell lines and its overexpression may serve as a prognostic marker in patients with urothelial carcinoma or ovarian cancer [29]–[31].